Mirxes

MiRXES is a Singapore-based biotechnology company that specializes in RNA-powered tests for early disease detection. Founded in 2014, MiRXES has grown into a global leader in miRNA technology and diagnostics, with a focus on developing and commercializing innovative tests for cancer, cardiovascular, metabolic, and infectious diseases. The company's flagship product, GASTROClear, is the world's first microRNA blood test for early detection of gastric cancer and has received regulatory approval from Singapore's Health Sciences Authority and the CE mark in the EU.

MiRXES has a strong research and development pipeline, with clinical validation studies conducted in collaboration with leading academic and clinical institutions in Singapore, the United States, China, Italy, and Japan. The company is committed to using its technology to improve healthcare outcomes and save lives by making early disease detection accessible to all. MiRXES is also dedicated to promoting diversity in its workforce and actively seeking new talents to join their team.

MiRXES is a Singapore-based biotechnology company focused on improving and saving lives by developing RNA-powered early detection tests for a variety of diseases, including cancer, cardiovascular, metabolic, and infectious diseases. The company strives to deliver accurate, actionable, and personalized diagnoses across the care continuum to help prevent disease and improve overall health outcomes. Their mission is to shift the healthcare paradigm from treating the sick to preventing disease through early detection and intervention.

MiRXES fosters a collaborative and driven culture, emphasizing innovation and teamwork to develop RNA-powered early disease detection tests. The company values diversity and inclusion, as demonstrated by their "Wonder Women" initiative and their commitment to providing equal opportunities for all Singaporeans. With a focus on continuous learning and improvement, MiRXES empowers its employees to take initiative, think outside the box, and contribute to a shared vision of improving and saving lives through cutting-edge biotechnology solutions.

MiRXES demonstrates a strong commitment to diversity, equity, and inclusion, evident in their efforts to promote a diverse workforce and encourage the advancement of underrepresented groups within STEM fields. The company celebrates women in science through their "TeamTalk: Meet the MiRXES Wonder Women" initiative, showcasing the impactful roles women play across various departments. They further highlight this commitment by partnering with Yayasan MENDAKI to establish the "MENDAKI - MiRXES Scholarship" specifically for Malay/Muslim students pursuing careers in Life and Biomedical Sciences. This scholarship scheme provides financial assistance, internship opportunities, and potential employment opportunities with MiRXES upon graduation, fostering inclusivity and diversity within the company and beyond.